Summary
This Patient Safety Supplement, issued by the Health Service Executive in the Republic of Ireland, aims to raise awareness among patients and healthcare staff of the risk of paracetamol-induced hepatotoxicity (harm to the liver) from standard doses of paracetamol in some adult patients. Paracetamol-induced hepatotoxicity may result in acute liver failure, the need for liver transplantation and/or death. Symptoms can include stomach pain, nausea (feeling sick) or vomiting, jaundice (skin or eyes look yellow), confusion, drowsiness or sleepiness and not urinating as much as normal.
Health Service Executive: Paracetamol dosing for adult patients under 50kg and those with additional risk factors for hepatotoxicity (11 May 2026)
https://www2.healthservice.hse.ie/organisation/nqpsd/pst/safety-supplements/paracetamol-dosing-for-adult-patients-under-50-kg-and-those-with-additional-risk-factors-for-hepatotoxicity/
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now